Accounting standards
Stock options at a private company: 409A values and the expense on your books
November 18, 2026 · 10 min read

Quick answer
A 409A valuation sets the fair market value of your common stock so you can grant options at an exercise price that won't trigger tax penalties for employees. Under ASC 718, the same value usually becomes the share price input for measuring each option's grant-date fair value, which you then expense over the vesting period. Private companies get shortcuts: since ASU 2021-07 they can use a qualifying 409A value as the current share price, and they can use a simplified expected term.
Your startup closed a seed round, ordered a 409A valuation, and the board granted options at the 409A price. Then your investors ask for GAAP financial statements, or an auditor asks where the stock compensation expense is.
That's when most founders learn a 409A valuation does two jobs. It protects employees on the tax side. And it feeds a non-cash expense that GAAP puts on your income statement, even though no money moves when you grant an option.
Below: how the two connect, the private-company shortcuts, and a worked example with the journal entry. The valuation itself comes from an independent appraiser, not your bookkeeper or controller.
12 months
Maximum age of an independent appraisal for the 409A safe-harbor presumption, and for the ASU 2021-07 expedient
20%
Additional federal tax on the option holder if an option fails 409A, plus interest
Grant date
When ASC 718 fixes the fair value of an equity-classified option
What is a 409A valuation, and why do you need one?
Section 409A of the tax code covers deferred compensation (more in our 409A valuation glossary entry). A stock option escapes 409A only if its exercise price can never be less than the fair market value of the underlying stock on the grant date. Grant an option below fair market value and it can be treated as deferred compensation that fails 409A. The statute then adds a 20% additional tax plus interest at the underpayment rate plus one percentage point, on top of ordinary income tax. That lands on the employee, not the company, which is exactly why nobody wants to get it wrong.
The problem is that private company stock has no market price. So the Treasury regulations give three valuation methods that are presumed reasonable, meaning the IRS can only challenge them by showing they were grossly unreasonable:
- An independent appraisal dated no more than 12 months before the grant. This is what almost every venture-backed startup uses.
- A formula price used consistently for all transfers of the stock.
- A written valuation of illiquid start-up stock by a qualified person, for a company that has had no material trade or business for 10 years or more, with no public trading and no sale or IPO reasonably expected within 90 or 180 days.
Twelve months is a ceiling, not a guarantee. A priced round, a big new contract or a lost customer can make the old valuation stale long before it ages out. Most companies get a new one at least yearly and after each financing.
How does the 409A value become an expense on your books?
ASC 718 says employee options are stock-based compensation. You measure each option's grant-date fair value using an option-pricing model (Black-Scholes is the usual one for plain options) and recognize that amount as expense over the period the employee has to work to earn it.
The model needs six inputs:
| Input | Where it comes from at a private company |
|---|---|
| Current share price | The 409A value (allowed directly under ASU 2021-07, if it qualifies) |
| Exercise price | The price in the grant, usually equal to the 409A value |
| Expected term | Often the private-company shortcut: midpoint of vesting and contractual term |
| Expected volatility | Usually a peer group of similar public companies, or an industry index |
| Risk-free rate | Treasury yield matching the expected term |
| Dividends | Usually zero for a startup |
Notice the 409A value appears twice. It's the exercise price and the share price. For an at-the-money option, those are equal, so the option has no intrinsic value on day one. It still has fair value, though, because it gives the employee years of upside without risking their own money. That time value is what you expense.
Protects employees
Tax (Section 409A)
- Sets the exercise price floor
- Presumption of reasonableness if appraised within 12 months
- Getting it wrong hits the option holder: income inclusion, 20% additional tax, interest
- Your CPA and legal counsel own this side
Measures the expense
Books (ASC 718)
- Feeds the share price input to the option model
- Produces a grant-date fair value per option
- Expensed over the vesting period as a non-cash cost
- Only matters if you report under GAAP
What shortcuts do private companies get?
More than people realize. Four matter most.
The current price expedient (ASU 2021-07). Before 2021, a private company technically had to estimate the fair value of its stock for accounting separately from the 409A, and many auditors pushed back on simply reusing the tax number. ASU 2021-07 lets nonpublic entities determine the current price input for equity-classified awards using a reasonable valuation method, and a valuation that meets the 409A regulations qualifies. The value can't be more than 12 months older than the grant, and it has to be updated for anything material that happened since. You elect it grant date by grant date, apply it to every award on the same shares with the same measurement date, and disclose that you used it. It's been effective since fiscal years beginning after December 15, 2021, so it's available now.
The expected term expedient. Estimating how long employees will hold options before exercising is guesswork at a young company. For at-the-money options without a market condition, a nonpublic entity can use the midpoint between the end of the vesting period and the contractual term. Four-year vesting and a 10-year term gives a 7-year expected term.
Calculated value. If you can't reasonably estimate your own volatility, you can use the historical volatility of an appropriate industry sector index instead.
Forfeitures. You can choose, as a company-wide policy, either to estimate how many options will be forfeited or to simply reverse expense when someone actually leaves before vesting. Most small companies pick "as they occur" because it's easier to keep accurate.
A worked example: two grants, one growing expense
Say you run a 30-person SaaS startup with a December year end and GAAP statements for your investors.
Grant A, January 2026. The board grants 240,000 options at $1.20, the value in a 409A appraisal from November 2025. Four-year vesting, 10-year term. Using the expected term expedient (7 years), 60% peer-group volatility, a 4.0% risk-free rate and no dividends, Black-Scholes gives $0.76 per option. Grant-date fair value: 240,000 × $0.76 = $182,400, expensed straight-line at $45,600 a year, or $3,800 a month.
Grant B, January 2027. After a Series A, a new 409A comes in at $2.10. The board grants 120,000 options at $2.10. With 55% volatility and the same other inputs, each option is worth $1.25. Grant-date fair value: 120,000 × $1.25 = $150,000, or $37,500 a year ($3,125 a month) over four years.
Stock option expense by year
Hypothetical SaaS startup, two grants, straight-line over four years
- Grant A (240,000 at $1.20)
- Grant B (120,000 at $2.10)
Hypothetical example, assumes no forfeitures. Grant A: 240,000 × $0.76 = $182,400 over 4 years. Grant B: 120,000 × $1.25 = $150,000 over 4 years. 2027 to 2029 total $83,100 a year.
Show the numbers
| Grant A (240,000 at $1.20) | Grant B (120,000 at $2.10) | |
|---|---|---|
| 2026 | $45,600 | $0 |
| 2027 | $45,600 | $37,500 |
| 2028 | $45,600 | $37,500 |
| 2029 | $45,600 | $37,500 |
| 2030 | $0 | $37,500 |
Each month in 2027 the entry is:
| Account | Debit | Credit |
|---|---|---|
| Stock-based compensation expense (split across R&D, sales and G&A by who holds the options) | $6,925 | |
| Additional paid-in capital | $6,925 |
No cash moves. Total equity doesn't change either: expense lowers retained earnings and APIC goes up by the same amount. But operating profit drops by $83,100 a year from 2027 to 2029, and that's the number investors and lenders read.
Two things change the picture. If the full 10-year contractual term were used instead of the 7-year expedient, Grant A would be worth about $0.87 an option, or $208,800 in total. And if an employee holding 24,000 Grant A options leaves before vesting, the "as they occur" policy reverses the expense recognized on their unvested options in the month they leave.
Common mistakes with options and 409A
Granting on a stale valuation. The board approves grants in March using a 409A from last April, after a priced round in January. The appraisal is technically under 12 months old, but a material event made it stale. That's a tax problem for employees and an audit problem for you.
Not booking the expense at all. Common at companies that only grant options a few times a year. It's invisible until an auditor or a buyer finds it, and then several years have to be fixed at once.
Using the grant date the cap table says, not the real one. Under ASC 718 the grant date is when the key terms are approved and communicated to the employee. A board consent signed weeks after the offer letter can shift the date and the value.
Ignoring cancellations and repricings. Repricing underwater options usually creates incremental expense, measured by comparing the option's value just before and after the change. It's not a free fix.
Forgetting the disclosures. GAAP statements need a note on the plan, the assumptions and, if you used it, the ASU 2021-07 expedient.
Do you even need to record stock option expense?
Only if your financial statements follow GAAP. If you report on a tax basis or cash basis (common for small private companies without outside investors), ASC 718 doesn't apply, and your CPA can tell you how your framework treats options, if at all. Our post on GAAP vs tax basis vs cash basis covers which one you need.
Once you have institutional investors, a lender asking for GAAP statements or an audit coming, you need it from the first grant. Rebuilding three years of grants later is far worse than one entry a month.
When should you get help?
If you've granted options to a handful of people and your statements aren't GAAP yet, a spreadsheet of grants and your 409A reports is enough for now. Keep the board consents, the valuation reports and the grant dates in one place.
Get help when you're preparing investor-ready books, facing a first audit, repricing options or granting across several 409A periods. A valuation firm prepares the 409A; Fintrix Consulting doesn't do valuations. What our accounting service does is close your books every month, with every entry, including the stock comp entry built from your grants and valuation reports, reviewed by someone who didn't prepare it.
Frequently asked questions
How often do we need a new 409A valuation?
At least every 12 months to keep the independent appraisal presumption, and sooner after a material event such as a priced financing round, a major contract or a big loss of business. Many startups get one right after each round.
Is the 409A value the same as our preferred stock price?
No. Investors buy preferred stock with rights common stock doesn't have, such as liquidation preferences. The 409A values common stock, so it's usually well below the latest preferred price.
Can we use our 409A value for the accounting?
Usually yes. Since ASU 2021-07, a nonpublic company can use a valuation that meets the 409A regulations as the current share price input for equity-classified awards, if it's not more than 12 months old and is updated for material later events. You disclose that you used the expedient.
Does stock option expense affect cash or taxes?
Not cash. The book expense is non-cash and is credited to equity. The tax deduction, if any, follows separate tax rules and timing, so ask your CPA how your option type (ISO or NSO) is treated.
What happens if employees never exercise their options?
For vested options that expire unexercised, the expense already recognized stays. You only reverse expense for options forfeited before they vest.
The bottom line
A 409A valuation sets the exercise price that keeps your employees clear of a 20% tax penalty, and under ASC 718 the same number usually feeds the option value you expense on your books. Private companies have real shortcuts: the ASU 2021-07 current price expedient, a simplified expected term and a choice on forfeitures. Keep valuations current, book the expense from the first grant if you report under GAAP, and keep the grant records clean. That way your first audit, or your first buyer, finds a schedule instead of a project.
Sources
- 26 CFR 1.409A-1, definitions and covered plans (stock rights, presumptions of reasonable valuation) (Cornell LII)
- 26 U.S. Code 409A (Cornell LII)
- ASU 2021-07 offers private company practical expedient (Grant Thornton)
- Share-based payment: private company practical expedient (KPMG)
- 6.2 Measurement of awards, nonpublic companies (PwC Viewpoint, Stock-based compensation guide)
- Share-based payment accounting (Journal of Accountancy)
- 409A Valuations: Understanding the Impact on Stock-Based Compensation (CBIZ)
This article is general information, not advice for your situation. Rules change and details matter, so talk to us or your CPA before acting on it.
More articles
- Found a mistake in last year's books? Errors vs changes in estimate
November 18, 2026
- Buying a business: the ASC 805 accounting checklist
November 18, 2026
- CECL isn't just for banks: the bad-debt allowance for your receivables
November 18, 2026
Have a question about this article?
Ask us. A real person will reply by email within one business day. Your question isn’t published.
Ready for books you can trust?
Book a free 30-minute consultation. We'll review where your finances stand today and show you exactly how we'd help.